UBS Group AG - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 183 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,577
+40.1%
3,725
+9.5%
0.00%
Q1 2023$2,553
+86.5%
3,403
-8.1%
0.00%
Q4 2022$1,369
+36.9%
3,701
+68.8%
0.00%
Q3 2022$1,000
-50.0%
2,193
+1.7%
0.00%
Q2 2022$2,000
-33.3%
2,1570.0%0.00%
Q1 2022$3,0000.0%2,1570.0%0.00%
Q4 2021$3,000
-99.9%
2,157
-99.8%
0.00%
-100.0%
Q3 2021$2,060,000
+397.6%
944,969
+756.2%
0.00%
Q2 2021$414,000
-59.3%
110,373
-64.7%
0.00%
Q1 2021$1,018,000
+5257.9%
312,250
+5531.2%
0.00%
Q4 2020$19,000
+5.6%
5,545
+25.0%
0.00%
Q3 2020$18,000
+5.9%
4,437
-10.5%
0.00%
Q2 2020$17,000
-81.7%
4,960
-87.5%
0.00%
Q1 2020$93,000
-25.0%
39,738
+16.4%
0.00%
Q4 2019$124,000
-91.7%
34,144
-81.1%
0.00%
-100.0%
Q3 2019$1,500,000
+3309.1%
180,883
+3450.9%
0.00%
Q2 2019$44,000
-26.7%
5,094
-8.8%
0.00%
Q1 2019$60,000
-96.7%
5,588
-97.3%
0.00%
-100.0%
Q4 2018$1,809,000
-64.7%
206,756
-32.3%
0.00%
-50.0%
Q3 2018$5,129,000
+11556.8%
305,318
+14522.5%
0.00%
Q2 2018$44,000
-98.9%
2,088
-99.2%
0.00%
-100.0%
Q1 2018$4,188,000
+187.6%
260,308
+238.7%
0.00%
Q4 2017$1,456,000
-26.1%
76,861
-45.1%
0.00%
-100.0%
Q3 2017$1,970,000
+185.1%
140,018
+50.8%
0.00%
Q2 2017$691,000
+95.8%
92,844
+71.2%
0.00%
Q1 2017$353,000
+100.6%
54,218
+36.6%
0.00%
Q4 2016$176,000
-45.8%
39,699
-42.9%
0.00%
Q3 2016$325,000
-50.2%
69,488
-30.0%
0.00%
Q2 2016$652,000
+150.8%
99,317
+142.8%
0.00%
Q1 2016$260,000
-80.9%
40,904
-81.9%
0.00%
-100.0%
Q4 2015$1,360,000
+268.6%
225,609
+265.6%
0.00%
Q3 2015$369,000
+954.3%
61,711
+1094.6%
0.00%
Q2 2015$35,000
+9.4%
5,166
-3.3%
0.00%
Q1 2015$32,000
-15.8%
5,341
+0.5%
0.00%
Q4 2014$38,0005,3140.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders